Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MOTHAFFAR RIMAWI and JONATHAN LEI.
MOTHAFFAR RIMAWI
Connection Strength
0.412
JONATHAN LEI
  1. Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses. bioRxiv. 2025 Jan 08.
    View in: PubMed
    Score: 0.248
  2. Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins. Cancer Res Commun. 2023 08; 3(8):1551-1563.
    View in: PubMed
    Score: 0.056
  3. Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach. iScience. 2023 Jan 20; 26(1):105799.
    View in: PubMed
    Score: 0.054
  4. Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 11 02; 12(11):2586-2605.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.